T. Maher

Royal Brompton Hospital

Poster Author Of 3 e-Posters

 ePosters
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A4085 - Effect of Nintedanib on Biomarkers of Extracellular Matrix (ECM) Turnover and FVC Decline in Patients with IPF: Results from the INMARK Study

Presenter:
Date
05/20/2019
Room
Room C140/C142 (Level 1), KBHCCD
Session Name
B103 - ILD: THERAPY
Session Type
RAPiD: Rapid Abstract Poster Discussion Session
Authors
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A4597 - Rationale, Design and Objectives of Two Phase III, Randomised, Placebo-Controlled Studies of GLPG1690, a Novel Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (ISABELA 1 and 2)

Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C34 - ILD AND IPF: CLINICAL AND MECHANISTIC STUDIES
Session Type
Thematic Poster Session
Authors
04. Autoimmune Lung Disease

A7360 - Nintedanib Reduces Lung Function Decline in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Results of the SENSCIS Trial

Presenter:
Date
05/20/2019
Room
Room C155-C156 (Level 1), KBHCCD
Session Name
B17 - ADVANCES IN ILD THERAPY
Session Type
Mini Symposium
Authors